GlaxoSmithKline (GSK) recently implemented a new platform that integrates and standardizes all of their data across their R&D division, which will transform the way they do drug discovery and clinical trials. The platform promises to completely change the drug discovery process and narrow down what usually takes a few years to 30 minutes. (Drug Discovery & Development)